Stocks · News reference
Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $57
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $48 to $57.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
PACS Group Subsidiaries Enter Into Definitive Agreements To Acquire Operations Of 32 Skilled Nursing Facilities Across Florida; Terms Not Disclosed
PACS Group, Inc. (NYSE:PACS) announced today that subsidiaries of the Company have entered into definitive agreements to acquire the operations of 32 skilled nursing facilities across Florida. The facilities will be
UBS Maintains Buy on PACS Group, Raises Price Target to $60
UBS analyst A.J. Rice maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $57 to $60.